CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 103 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 2.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 1,401,422 | $42,113,000 | 92.36% |
| VR Adviser, LLC | 4,016,873 | $120,707,000 | 28.90% |
| Svennilson Peter | 6,051,376 | $181,844,000 | 15.21% |
| GREAT POINT PARTNERS LLC | 3,480,000 | $104,574,000 | 8.36% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,237,406 | $37,184,000 | 5.22% |
| Ghost Tree Capital, LLC | 650,000 | $19,533,000 | 5.15% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $42,070,000 | 4.41% |
| Venrock Management V, LLC | 1,557,276 | $46,796,000 | 3.94% |
| Venrock Partners Management V, LLC | 132,026 | $3,967,000 | 3.94% |
| Avoro Capital Advisors LLC | 4,000,000 | $120,200,000 | 2.38% |